منابع مشابه
"Increasing brain tumor rates: is there a link to aspartame?".
In the past two decades brain tumor rates have risen in several industrialized countries, including the United States. During this time, brain tumor data have been gathered by the National Cancer Institute from catchment areas representing 10% of the United States population. In the present study, we analyzed these data from 1975 to 1992 and found that the brain tumor increases in the United St...
متن کاملAspartame consumption in relation to childhood brain tumor risk: results from a case-control study.
Brain cancer incidence rates in the United States have been increasing in both adults (1) and children (2). The possibility that aspartame, a widely ingested artificial sweetener, may be a cause of brain cancer in humans was suggested in a recent report by Olney et al. (3). From a descriptive analysis of national cancer data, they noted increased brain cancer incidence rates in the United State...
متن کاملAspartame and incidence of brain malignancies.
To the Editors: Lim et al. (1) found no relationship between the ''Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies'' by surveying retired individuals about their consumption of diet sodas and determining whether they had an increase in brain tumors 5 years later. In fact, this study design was not able to test the hypothesized relationship bec...
متن کاملAspartame consumption and incidence of hematopoietic and brain cancers.
To the Editors: Lim et al. (1), using data from the 1995 to 1996 NIH-AARP Diet and Health Study, tested the hypothesis that aspartame consumption is associated with risk of hematopoietic cancers or gliomas (2). However, inappropriateness of subjects and study protocols renders any conclusions drawn from the Lim et al. study meaningless. Basic flaws are each significant enough to invalidate the ...
متن کاملO 25: Immunotherapy for Brain Tumor
In 1890, Coley observed that cancer patients who developed infections had smaller tumors. From this, he developed Coley’s toxin and treated tumors with injections of infectious materials. In 1960s, Mahaley used monoclonal antibodies to treat central nervous system(CNS) tumors, that research and clinical investigations in brain tumor immunotherapy became a serious undertaking. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Neurology Briefs
سال: 1997
ISSN: 2166-6482,1043-3155
DOI: 10.15844/pedneurbriefs-11-1-4